Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate
Josefa Zaldívar-Díez(Centro de Investigaciones Biológicas Margarita Salas), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Cristina Medina-Menéndez(Instituto Cajal), Carmen Gil(Instituto de Salud Carlos III), Aixa V. Morales(Instituto Cajal), Stephen J. Haggarty(Harvard University), Wen‐Ning Zhao(Massachusetts General Hospital), Lingling Li(Guizhou Academy of Agricultural Sciences), Ana M. García(University of Trieste)
Cited by 25
Related Papers
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Epigenetic Priming of Memory Updating during Reconsolidation to Attenuate Remote Fear Memories
|Cell|2014|364
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348